Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.47 USD | -6.16% | -6.39% | +522.50% |
Jun. 04 | Maxim Downgrades ZIVO Bioscience to Hold From Buy | MT |
May. 13 | ZIVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+522.50% | 21.31M | |
+10.73% | 8.07B | |
+8.44% | 7.84B | |
-0.58% | 6.07B | |
-6.24% | 3.71B | |
-13.21% | 3.49B | |
-15.49% | 1.15B | |
+9.98% | 957M | |
-10.15% | 931M | |
-13.30% | 832M |
- Stock Market
- Equities
- ZIVO Stock
- News ZIVO Bioscience, Inc.
- ZIVO Bioscience Appoints Chairman John Payne as President, Chief Executive